Dansky, Peter M. (Agena Bioscience 201407– CEO before Life Technologies + Applied Biosystems + Arcturus + Affymetrix) |
Chief Executive Officer (CEO) |
Thermo Fisher (Group) |
United States (USA) |
Danzl, Michael (Actelion 201606 General Manager at Actelion Germany) |
General Manager (management) |
Johnson & Johnson (JnJ) (Group) |
Germany |
Darbouret, Bruno (Thermo Fisher 201109 Director RnD BRAHMS Biomarkers) |
Research & Development Manager |
Thermo Fisher (Group) |
Germany |
Darcissac, Camille (Adocia 202005 Business Development + Strategic Marketing) |
Business Development Manager / Strategy Manager |
Adocia S.A. |
France |
Dargel, Christian (Breakpoint Therapeutics 201906– Managing Director) |
Managing Director |
Breakpoint Therapeutics GmbH |
Germany |
Darr, William (ADF/IDF 201901 Founder) |
Company Founder |
Symrise (Group) |
United States (USA) |
Dartsch, Stefan (Ionovation 201206 Managing Director) |
Managing Director |
Ionovation GmbH |
Germany |
Das, Annapurna (Miltenyi Biotec 202402 Managing Director India + Area Head India + Southeast Asia) |
Managing Director |
Miltenyi Biotec (Group) |
India |
Dasberg, David (Facio Therapies 201504 Managing Director) |
Managing Director |
Facio Therapies B.V. |
Netherlands |
Datla, Vijay Kumar (Biological E 201109 Managing Director) |
Managing Director |
Biological E. Ltd. |
India |
Datta, Merrilyn (Definiens 201304– Chief Marketing Officer based in Carlsbad, CA before Life Technologies) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
United States (USA) |
Daub, Achim (Symrise 201404 Global President Scent + Care) |
President/Director/Head Business Group/Unit/Division |
Symrise (Group) |
Germany |
Daub, Henrik (MPI for Biochemistry 200603) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
Dauer, Ulrich (Probiodrug 201805– CEO before Omeicos + Activaero + 4SC + Tripos) |
Chief Executive Officer (CEO) |
Vivoryon (Group) |
Germany |
Daujotyte, Dalia (Lexogen 201806 Head of Business Development) |
Business Development Manager / Strategy Manager |
Lexogen GmbH |
Austria |
Daukandt, Marc (Xpress Biologics 202212 CEO) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
Belgium |
Daum, Dieter (Sony 201203 CEO of Sony DADC) |
Chief Executive Officer (CEO) |
Sony (Group) |
Austria |
Daumke, Philipp C. (Averbis GmbH 2007– Managing Director + Co-Founder) |
Managing Director |
Acus Laboratories GmbH |
Germany |
Dausend, Melanie (Univ Wuppertal 201005 Analytical Service Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Wuppertal |
Germany |
Dauwalder, Magali (SGS 202307 Media Relations) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Switzerland |
Daußmann, Thomas (Enzymaster 202205 Managing Director of Enzymaster Deutschland GmbH) |
Managing Director |
Enzymaster (Group) |
Germany |
David, Rainer (Eppendorf 201709 Managing Director at Eppendorf Polmyere GmbH) |
Managing Director |
Eppendorf (Group) |
Germany |
Davidson, Eran (HassoPlattnerVentures 200506 + DBI AG 201508 Supervisory Board Member) |
Investment Manager |
HassoPlattnerVentures Management GmbH |
Germany |
Davidson, Jostein (Nycomed 201108 SVP + President of Nycomed Russia-CIS) |
President/Director/Head Business Group/Unit/Division |
Takeda (Group) |
Switzerland |
Davidson, Kent (Thermo Fisher 202109 VP + General Manager High Performance Chromatography Solutions) |
General Manager (management) |
Thermo Fisher (Group) |
United States (USA) |
Davies, Hugh (Kinesis 201201 Managing Director of Abimed GmbH) |
Managing Director |
Antylia Scientific (Group) |
Germany |
Davies, Mike (F-Star 201606 VP Protein Science) |
n. a. |
Sino Biopharm (Group) |
United Kingdom (GB) |
Davies, Richard (BoneSupport 201601– CEO before Hospira CCO) |
Chief Commercial Officer (CCO) |
BoneSupport (Group) |
Sweden |
Davies, Steve (Markes International 201212 Product Manager at Almsco International) |
Product Manager (personnel) |
Schauenburg (Group) |
United Kingdom (GB) |
Davis, Darren (ApoCell 201311 CEO) |
Chief Executive Officer (CEO) |
ApoCell (Group) |
United States (USA) |
Davis, Paul (Roivant 201708 Manager Communications Strategy) |
Public Relations Manager / Investor Relations Manager |
Roivant (Group) |
United States (USA) |
Davis, Richard (Rick) (Nouscom 202205 CBO formerly Wellcome Trust) |
Chief Business Officer (CBO) |
Nouscom (Group) |
Switzerland |
Dawkins, Keith D. (Shockwave 2019– CMO before Boston Scientific) |
Board member, non-executive |
|
|
Dawson, John (Alliance Pharma 201306 CEO + Founder) |
Chief Executive Officer (CEO) |
Alliance Pharma (Group) |
United Kingdom (GB) |
Day, Adrienne (Burnham 200611 VP Business Development) |
Business Development Manager / Strategy Manager |
Burnham Institute |
United States (USA) |
de Andrade, Gonçalo Rebelo (Indaco Venture 202403 Partner at Indaco Bio Fund) |
Partner (venture partner) |
Indaco Venture (Group) |
Italy |
de Angelis, Hrabe (GSF Munich 200705– Director) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
de Backer, Hans (Pepscan 202306 CEO) |
Chief Executive Officer (CEO) |
Biosynth (since 9/22) (Group) |
Netherlands |
De Backer, Marianne (Bayer 202008 Excecutive Committee Memmber + Head of Strategy + BusDev + Licensing at Pharma div) |
Business Development Manager / Strategy Manager |
Bayer (Group) |
Germany |
de Baey, Annegret (BPCE 202110 Venture Partner at Seventure Partners before Rigontec + GIMV + TVM Capital + Micromet) |
Managing Director |
BPCE (Group) |
France |
de Beer, Joel (Anjarium Biosciences 202109 CSO + Founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Anjarium Biosciences AG |
Switzerland |
De Beuckelaer, Ann (BioMed X 201609 Managing Director) |
Managing Director |
BioMed X GmbH |
Germany |
de Bie, Johannes Hendrik (Hans) (WeissBioTech 201210– Managing Director) |
Managing Director |
BRAIN Biotech (Group) |
Germany |
de Boer, Mark (Index Ventures 200708 General Partner) |
Venture Partner |
Index Ventures |
Switzerland |
de Bruijn, Joost (Kuros 201711– CEO before Managing Director + Co-Founder of Xpand Biotechnology before IsoTis) |
Chief Executive Officer (CEO) |
Kuros (Group) |
Switzerland |
de Buijzer, Erwin (Link Medical 202104– Medical Device Director in Germany before Humedics + Eurotransplant) |
CRO |
Link Medical (Group) |
Norway |
de Buman, Jean-Luc (SGS 201505 Corp Development, Communications + PR) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Switzerland |
de Crémoux, Isabelle (BPCE 201110– CEO of Seventure Partners) |
Chief Executive Officer (CEO) |
BPCE (Group) |
France |
De Greef-Safft, Anne (Danaher 200901 President Leica Microsystem Biosystems Division) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
Germany |
de Groot, Robert (EU (govt) 202407 VP of EIB) |
President/Director/Head Business Group/Unit/Division |
EU (govt) |
Luxembourg |
de Haard, Hans (Argen-X 201203 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Argenx (Argen-X) (Group) |
Netherlands |
De Haes, Patrik (ThromboGenics 200808– CEO before Roche Diagnostics) |
Chief Executive Officer (CEO) |
Oxurion (Group) |
Belgium |
de Jager, Jost (Schleswig-Holstein 201004 Minister of Science, Economic Affairs and Transport) |
Minister |
Schleswig-Holstein (govt region) |
Germany |
De Jesus, Linda (Azenta 202208 SVP + Chief Commercial Officer before Thermo Fisher) |
Chief Commercial Officer (CCO) |
Azenta (Group) |
United States (USA) |
de Jong, Andy (Paleo 202302 COO + Co-Founder) |
Chief Operating Officer (COO) |
Paleo B.V. |
Belgium |
de Koning, John (Life Sciences Partners 201603 Partner) |
Partner (venture partner) |
EQT (Wallenberg family) (Group) |
Netherlands |
de La Fortelle, Eric (Delenex 201102– CEO before Roche) |
Partner (venture partner) |
BPCE (Group) |
France |
de la Huerta Martinez, Pilar (Sygnis Pharma 201303– CEO + CFO before Genetrix CEO before Zeltia) |
Chief Executive Officer (CEO) |
2invest (Group) |
Germany |
de La Sablière, Alban (Owkin 202210–CBO before at Sanofi since 2016 before Morgan Stanley France M&A Practice) |
Chief Business Officer (CBO) |
Owkin (Group) |
France |
de Lange, Lex (Zernike 201008) |
Chief Executive Officer (CEO) |
Zernike (Group) |
Netherlands |
De Leenheer, Frank (Gimv 201509 IR + Corporate Communications Manager) |
Public Relations Manager / Investor Relations Manager |
Gimv (Group) |
Belgium |
de Léon, Alethia (Basel (govt) 201702 Managing Director of BaseLaunch) |
Managing Director |
Basel (govt city) |
Switzerland |
De Libero, Gennaro (Univ Basel 201506 Professor of Immunology) |
Professor |
University of Basel |
Switzerland |
De Luca, Cris (Sanofi 202203 Global Head Digital Investments at Sanofi Ventures) |
Partner (venture partner) |
Sanofi (Group) [since May 2011] |
France |
De Paoli, Isabel (Merck (DE) 201508– Head Group Communications joined Merck 2006 before Boston Consulting + Permira) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
De Ponti, Roberto (Helsinn 201804 Head New Venture + Strategic Investment at Helsinn International Services) |
Investment Manager |
Helsinn (Group) |
Monaco |
de Rubertis, Francesco (Medecxi Ventures 201602 General Partner before Index Ventures 200708 General Partner) |
General Partner (venture partner) |
Medicxi Ventures (formerly Index Ventures Life Sciences) |
United Kingdom (GB) |
de Ruiter, Tjerk (EuropaBio 201809 Chair) |
lobbying |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
de Schoulepnikoff, Laurence (Tridek-One 202207– CEO before Amal Therapeutics) |
Chief Executive Officer (CEO) |
Tridek-One Therapeutics SAS |
France |
de Vladar, Harold P. (Ribbon Biolabs 202105 Managing Director + Founder) |
Managing Director |
Ribbon Biolabs GmbH |
Austria |
de Vreeze, Dimitri (DSM 202205 Co-CEO) |
Chief Executive Officer (CEO) |
DSM (Group) |
Netherlands |
de Vries, Erik (BRAIN Biotech 202406– Senior BusDev Director Enzymes before Enzymicals + Consultant + Dottikon + Amyris) |
Business Development Manager / Strategy Manager |
BRAIN Biotech (Group) |
Germany |
de Vries, Sijmen (Pharming 200810– CEO before 4-Antibody CEO before Morphochem before Novartis + SKB) |
Chief Executive Officer (CEO) |
Pharming (Group) |
Netherlands |
de Wit, Christina (Germany (govt) 201604 BMBF Division Bio-Economy) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
de Wit, Hugo (Cellca GmbH 201201– Managing Director before CBO) |
Managing Director |
Sartorius (Group) |
Germany |
Debatin, Frank Felix (North Data GmbH 202302 CEO + Founder) |
Managing Director |
North Data GmbH |
Germany |
Debatin, Jörg F. (General Electric 201408– CP + CTO at GE Healthcare before Amedes + Univ Medical Center Eppendorf) |
Chief Technology/Technical Officer (CTO) |
General Electric (Group) |
United Kingdom (GB) |
Debel, Karsten (Zytomed Systems 200912 Managing Director) |
Managing Director |
ZytoVision (Group) |
Germany |
deBethizy, J. Donald (Santaris Pharma 201401– CEO before Targacept CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
Denmark |
Debruyne, Luc (GSK 201504 President of GSK Vaccines) |
President/Director/Head Business Group/Unit/Division |
GSK (Group) |
Belgium |
Debus, Nils P. (iOmx Therapeutics 202309– CBO before OSE Immunotherapeutics + Boehringer + Merz + Schering) |
Chief Business Officer (CBO) |
iOmx Therapeutics AG |
Germany |
Dec, Timothy C. (OpGen 201909 CFO) |
n. a. |
OpGen (Group) |
United States (USA) |
Decadt, Yves (BioLingus 202001 CEO) |
Chief Executive Officer (CEO) |
BioLingus AG |
Switzerland |
Decker, Elke (GATC 200701 Senior Director Marketing) |
n. a. |
Eurofins (Group) |
Germany |
Deckers, Sjaak (G-Therapeutics 201604 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
G-Therapeutics (Group) |
Netherlands |
Deckert, Volker (University of Jena + Leibniz Institute of Photonic Technology) |
Researcher (university / research institute) |
University of Jena (Friedrich-Schiller-Universität Jena) |
Germany |
Decouttere, Frederik (Genohm 2010– CEO before CTO + Co-Founder) |
Chief Executive Officer (CEO) |
Agilent (Group) |
Switzerland |
Deda, Henri (Lipotype 201802– Marketing Assistant) |
n. a. |
Lipotype GmbH |
Germany |
Deeg, Maria (Creather Venture 201207 Investment Managerin) |
Investment Manager |
Creathor Ventures (Group) |
Germany |
DeHaan, Nick (Celeris Therapeutics 202111– VP Head of Partnering before Atomwise) |
Business Development Manager / Strategy Manager |
Celeris Therapeutics (CelerixTx) (Group) |
United States (USA) |
Dehning, Carsten (Adcytherix 202406 CFO before Emergence Therapeutics + Albireo + DeveloGen) |
Chief Financial Officer (CFO) |
Adcytherix SAS |
France |
Deichmann, Annette (GeneWerk GmbH 201709 Managing Director) |
Managing Director |
ProtaGene (Group) |
Germany |
Deichmann, Thomas (BRAIN AG 201712 Head of Public Relations) |
Public Relations Manager / Investor Relations Manager |
BRAIN Biotech (Group) |
Germany |
Deigin, Yuri (Youth Bio 202209 CEO) |
Chief Executive Officer (CEO) |
Youth Bio |
|
Deininger, Sören-Oliver (Bruker 200905 Bruker Daltonics MALDI Imaging Specialist) |
n. a. |
Bruker (Group) |
United States (USA) |
Deininger, Werner (Entelechon GmbH 200709 Managing Director) |
Managing Director |
Eurofins (Group) |
Germany |
Dekeyser, Rudy (Life Sciences Partners 201403 Managing Partner LSP HEF) |
Managing Partner |
EQT (Wallenberg family) (Group) |
Netherlands |
Dekkers, Marijn E. (Novalis LifeSciences 202208 Chairman + Founder before Bayer CEO + Thermo Fisher CEO) |
Company Founder |
Novalis LifeSciences LLC |
United States (USA) |
Del Bono, Alessandro (Mediolanum 201612 CEO) |
Chief Executive Officer (CEO) |
Mediolanum (Group) |
Italy |
Del Bono, Cristina (Mediolanum 201612 Licensing + Business Development Director) |
Business Development Manager / Strategy Manager |
Mediolanum (Group) |
Italy |